Discovery of a New Class of Non-imidazole Oxazoline-Based Histamine H3Receptor (H3R) Inverse Agonists-Reference-Cited by-同舟云学术

Discovery of a New Class of Non-imidazole Oxazoline-Based Histamine H3Receptor (H3R) Inverse Agonists

Published:2009-07-06 Issue:7 Volume:4 Page:1063-1068
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Célanire Sylvain,Wijtmans Maikel,Christophe Bernard,Collart Philippe,de Esch Iwan,Dassesse Donald,Delaunoy Christel,Denonne Frédéric,Durieu Véronique,Gelens Edith,Gillard Michel,Lallemand Bénédicte,Lamberty Yves,Lebon Florence,Nicolas Jean-Marie,Quéré Luc,Snip Erwin,Vanbellinghen Alain,Van houtvin Nathalie,Verbois Valérie,Timmerman Henk,Talaga Patrice,Leurs Rob,Provins Laurent

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cmdc.200900055/fullpdf

Reference26 articles.

1. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor

2. Constitutive activity of the histamine H3 receptor

3. Drug Discovery

4. Histamine H3 Receptor Antagonists Go to Clinics

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Samelisant (SUVN-G3031), a potent, selective and orally active histamine H3 receptor inverse agonist for the potential treatment of narcolepsy: pharmacological and neurochemical characterisation;Psychopharmacology;2021-02-07

2. Versatile Photochemical Reactivity of Diverse Substituted 2-, 4- and 5-(o -Vinylstyryl)oxazoles;European Journal of Organic Chemistry;2018-01-25

3. Iodoarene-catalyzed cyclizations of N-propargylamides and β-amidoketones: synthesis of 2-oxazolines;Beilstein Journal of Organic Chemistry;2017-08-31

4. The Orphan Receptor GPR17 Is Unresponsive to Uracil Nucleotides and Cysteinyl Leukotrienes;Molecular Pharmacology;2017-03-02

5. Lead Generation Paved the Way for the Discovery of a Novel H 3 Inverse Agonist Clinical Candidate;Methods and Principles in Medicinal Chemistry;2016-03-04